uniQure N.V.
uniQure N.V. (0EE0.L) Financial Performance & Income Statement Overview
Analyze uniQure N.V. (0EE0.L) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
uniQure N.V. (0EE0.L) Income Statement & Financial Overview
Analyze uniQure N.V.’s 0EE0.L earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.57M | $5.22M | $2.29M | $11.13M |
| Cost of Revenue | $197000.00 | $619000.00 | $1.02M | $10.13M |
| Gross Profit | $1.37M | $4.60M | $1.27M | $995000.00 |
| Gross Profit Ratio | $0.87 | $0.88 | $0.55 | $0.09 |
| R&D Expenses | $36.14M | $38.84M | $30.59M | $35.44M |
| SG&A Expenses | $10.91M | $9.40M | $11.57M | $13.10M |
| Operating Expenses | $47.05M | $50.43M | $41.49M | $48.39M |
| Total Costs & Expenses | $47.24M | $51.05M | $42.43M | $58.52M |
| Interest Income | $4.13M | $4.24M | $4.87M | $5.80M |
| Interest Expense | $15.11M | $14.88M | $16.61M | $16.16M |
| Depreciation & Amortization | $0.00 | $4.36M | $2.99M | $2.67M |
| EBITDA | -$39.33M | -$53.17M | -$24.81M | -$36.52M |
| EBITDA Ratio | -$25.10 | -$10.18 | -$10.85 | -$3.28 |
| Operating Income | -$39.33M | -$45.83M | -$40.23M | -$47.40M |
| Operating Income Ratio | -$25.10 | -$8.78 | -$17.59 | -$4.26 |
| Other Income/Expenses (Net) | -$3.81M | -$26.58M | -$4.18M | -$11.34M |
| Income Before Tax | -$43.14M | -$72.41M | -$44.41M | -$55.35M |
| Income Before Tax Ratio | -$27.53 | -$13.87 | -$19.42 | -$4.97 |
| Income Tax Expense | -$496000.00 | $856000.00 | -$31000.00 | $948000.00 |
| Net Income | -$43.64M | -$73.26M | -$44.38M | -$56.30M |
| Net Income Ratio | -$27.85 | -$14.03 | -$19.40 | -$5.06 |
| EPS | -$0.82 | -$1.51 | -$0.91 | -$1.16 |
| Diluted EPS | -$0.82 | -$1.51 | -$0.91 | -$1.16 |
| Weighted Avg Shares Outstanding | $53.11M | $48.84M | $48.72M | $48.62M |
| Weighted Avg Shares Outstanding (Diluted) | $53.11M | $48.84M | $48.72M | $48.62M |
Financial performance has remained strong, with revenue growing from $11.13M in Q2 2024 to $1.57M in Q1 2025. Gross profit continued to perform well, with margins at 87% in the latest quarter. Operating income reached -$39.33M in Q1 2025, holding a steady -2510% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$39.33M. Net income rose to -$43.64M, keeping EPS at -$0.82. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan